--- title: "NHS National Framework Agreement for the supply of products for the treatment of Bleeding Disorders, including Haemophilia B" ocid: "ocds-h6vhtk-030881" canonical_url: "https://d3tenders.com/contract/?ocid=ocds-h6vhtk-030881" markdown_url: "https://d3tenders.com/contract/ocds-h6vhtk-030881.md" json_url: "https://d3tenders.com/contract/ocds-h6vhtk-030881.json" source: "Find A Tender Service" current_stage: "Award" buyer: "NHS ENGLAND" published: "2022-07-04" --- # NHS National Framework Agreement for the supply of products for the treatment of Bleeding Disorders, including Haemophilia B Buyer: NHS ENGLAND Current stage: Award OCID: ocds-h6vhtk-030881 [View canonical contract page](https://d3tenders.com/contract/?ocid=ocds-h6vhtk-030881) [Download OCDS JSON](https://d3tenders.com/contract/ocds-h6vhtk-030881.json) ## Summary On 1 July 2022, NHS England commenced the National Framework Agreement for the supply of products for the treatment of Bleeding Disorders, including Haemophilia B. This procurement falls under the goods category and is classified under blood coagulants (CPV code 33141530). The framework is structured for a period of 24 months with an option to extend up to an additional 24 months, potentially totalling 48 months. Bids were invited through an open procurement process, and the tender will involve various lots including Fresh Frozen Plasma and Prothrombin Complex dried. The award period began on 14 February 2022, aligning with the tender's closing date for submissions. This tender represents substantial growth opportunities for suppliers in the healthcare sector, particularly those specialising in blood products and related medical supplies. Companies that can demonstrate reliability in supply and maintain competitive pricing, along with the capability to meet NHS standards, will be well-positioned to participate. Businesses focusing on innovative solutions for Haemophilia and similar conditions, or those with established experience supplying NHS entities or other healthcare providers, are encouraged to engage with this framework agreement. ## Notice National Framework Agreement for the supply of products for the treatment of Bleeding Disorders including Haemophilia B. The framework will commence on 1 July 2022 for a period of 24 months with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 24 moths. Total maximum framework agreement including extension options will be no more than 48 months. Please refer to the invitation to offer documents for a list of the purchasing points. ### Lot Information Lot 18 - Fresh Frozen Plasma Fresh Frozen Plasma Options: Option or Options to extend (at the Authority's discretion) for a period or periods up to a total of 24 months. Total maximum framework agreement, including extension options, will be no more than 48 months Lot 16 - Prothrombin Complex dried Prothrombin Complex dried Options: Option or Options to extend (at the Authority's discretion) for a period or periods up to a total of 24 months. Total maximum framework agreement, including extension options, will be no more than 48 months Lot 15 - Fibrinogen Concentrate Fibrinogen Concentrate Options: Option or Options to extend (at the Authority's discretion) for a period or periods up to a total of 24 months. Total maximum framework agreement, including extension options, will be no more than 48 months Lot 14 - Von willebrands factor - Recombinant Von willebrands factor - Recombinant Options: Option or Options to extend (at the Authority's discretion) for a period or periods up to a total of 24 months. Total maximum framework agreement, including extension options, will be no more than 48 months Lot 17 - Protein C Concentrate Protein C Concentrate Options: Option or Options to extend (at the Authority's discretion) for a period or periods up to a total of 24 months. Total maximum framework agreement, including extension options, will be no more than 48 months Lot 10 - Factor XIII - Plasma Derived Factor XIII - Plasma Derived Options: Option or Options to extend (at the Authority's discretion) for a period or periods up to a total of 24 months. Total maximum framework agreement, including extension options, will be no more than 48 months Lot 11 - Factor XIII - Recombinant Factor XIII - Recombinant Options: Option or Options to extend (at the Authority's discretion) for a period or periods up to a total of 24 months. Total maximum framework agreement, including extension options, will be no more than 48 months Lot 9 - Factor X Factor X Options: Option or Options to extend (at the Authority's discretion) for a period or periods up to a total of 24 months. Total maximum framework agreement, including extension options, will be no more than 48 months Lot 8 - Factor IX - High Purity Factor IX Factor IX - High Purity Factor IX Options: Option or Options to extend (at the Authority's discretion) for a period or periods up to a total of 24 months. Total maximum framework agreement, including extension options, will be no more than 48 months Lot 7 - Factor VIII Inhibitor Bypassing Fraction Factor VIII Inhibitor Bypassing Fraction Options: Option or Options to extend (at the Authority's discretion) for a period or periods up to a total of 24 months. Total maximum framework agreement, including extension options, will be no more than 48 months Lot 13 - Von willebrands factor - Plasma Derived Von willebrands factor - Plasma Derived Options: Option or Options to extend (at the Authority's discretion) for a period or periods up to a total of 24 months. Total maximum framework agreement, including extension options, will be no more than 48 months Lot 12 - Factor VIII/ von willebrands factor Factor VIII/ von willebrands factor Options: Option or Options to extend (at the Authority's discretion) for a period or periods up to a total of 24 months. Total maximum framework agreement, including extension options, will be no more than 48 months Lot 6 - Porcine Factor VIII - susoctocog alfa Porcine Factor VIII - susoctocog alfa Options: Option or Options to extend (at the Authority's discretion) for a period or periods up to a total of 24 months. Total maximum framework agreement, including extension options, will be no more than 48 months Lot 5 - Recombinant Factor VII Recombinant Factor VII Options: Option or Options to extend (at the Authority's discretion) for a period or periods up to a total of 24 months. Total maximum framework agreement, including extension options, will be no more than 48 months Lot 4 - rFIX - Standard Half Life rFIX - Standard Half Life Options: Option or Options to extend (at the Authority's discretion) for a period or periods up to a total of 24 months. Total maximum framework agreement, including extension options, will be no more than 48 months Lot 3 - nonacog beta pegol (rFIX EHL) nonacog beta pegol (rFIX EHL) Options: Option or Options to extend (at the Authority's discretion) for a period or periods up to a total of 24 months. Total maximum framework agreement, including extension options, will be no more than 48 months Lot 2 - albutrepenonacog alfa (rFIX EHL) albutrepenonacog alfa (rFIX EHL) Options: Option or Options to extend (at the Authority's discretion) for a period or periods up to a total of 24 months. Total maximum framework agreement, including extension options, will be no more than 48 months Lot 1 - eftrenonacog alfa (rFIX EHL) eftrenonacog alfa (rFIX EHL) Options: Option or options to extend (at the Authority's discretion) for a period or periods up to a total of 24 months. Total maximum framework agreement including extension options will be no more than 48 months ## Key Details | Field | Value | | --- | --- | | Publication source | Find A Tender Service | | Latest notice | https://www.find-tender.service.gov.uk/Notice/018165-2022 | | Notice type | Tender Notice | | Procurement type | Framework | | Procurement category | Goods | | Procurement method | Open | | Procurement method details | Open procedure | | Tender suitability | Not specified | | Awardee scale | Large, SME | | All stages | Tender, Award | ## Dates | Field | Value | | --- | --- | | Publication date | 4 Jul 2022 | | Submission deadline | 14 Feb 2022 | | Future notice date | Not specified | | Award date | 14 Jun 2022 | | Contract period | 30 Jun 2022 - 30 Jun 2024 | | Recurrence | Not specified | ## Values | Field | Value | | --- | --- | | Tender value | £500,000,000 | | Lots value | £18 | | Awards value | Not specified | | Contracts value | £1 | ## Status | Field | Value | | --- | --- | | Tender status | Complete | | Lots status | Cancelled | | Awards status | Active | | Contracts status | Active | ## Buyer | Field | Value | | --- | --- | | Main buyer | NHS ENGLAND | | Additional buyers | THE NHS COMMISSIONING BOARD (OPERATING UNDER THE NAME OF NHS ENGLAND) | | Locality | RUNCORN | | Post town | Warrington | | Postcode | WA7 2ES | | Country | England | | ITL 1 | TLE Yorkshire and The Humber | | ITL 2 | TLE4 West Yorkshire | | ITL 3 | TLE42 Leeds | | Local authority | Leeds | | Electoral ward | Little London & Woodhouse | | Westminster constituency | Leeds Central and Headingley | | Delivery location | Not specified | ## Supplier | Field | Value | | --- | --- | | Number of suppliers | 8 | | Supplier names | BIO PRODUCTS LABORATORY; CSL BEHRING; LFB; NOVO NORDISK; OCTAPHARMA; PFIZER; SOBI (SWEDISH ORPHAN BIOVITRUM; TAKEDA | ## CPV Codes ### Divisions - 33 - Medical equipments, pharmaceuticals and personal care products ### Codes - 33141530 - Blood coagulants ## Release History - 4 Jul 2022 at 13:02 - Award - Award Notice - https://www.find-tender.service.gov.uk/Notice/018165-2022 - 7 Jan 2022 at 13:22 - Tender - Tender Notice - https://www.find-tender.service.gov.uk/Notice/000489-2022 ## Notice URLs - http://health.atamis.co.uk - https://health-family.force.com/s/Welcome - https://healthfamily.force.com/s/Welcome - https://supplierregistration.cabinetoffice.gov.uk - https://www.england.nhs.uk/ - https://www.gov.uk/courts-tribunals ## Provenance This Markdown file is an alternate public rendering of the D3 Tenders contract record. The canonical page is https://d3tenders.com/contract/?ocid=ocds-h6vhtk-030881. The underlying structured data is available as OCDS JSON at https://d3tenders.com/contract/ocds-h6vhtk-030881.json.